Eyestem Research Is A Clinical Stage Biotechnology Company Based In Bangaloreindiaand Delawareusafounded In 2016The Company Focuses On Developing Scalable Cell Replacement Therapies For Incurable Diseasesparticularly In The Field Of Ophthalmologyits Lead Producteyecyte Rpeis Designed To Treat Dry Age Related Macular Degenerationamd A Major Cause Of Blindnesseyestem Has Conducted Dose Ranging Studies In Animals And Is Currently Engaged In Pivotal Efficacy And Safety Studies At Oregon Health And Science University The Company Aims To Make Cell Therapies More Accessible And Affordabletargeting The Global Population Affected By Dry Amdeyestem Collaborates With Leaders In Cell Therapy And Ophthalmology Across Multiple Countriesincluding Indiathe Ukjapanand The Usarecognized For Its Contributions To Cell Therapyeyestem Has Received Awards And Grants From The Department Of Biotechnology In Indiaits Strategy Includes Integrating Manufacturing And Quality Processes To Enhance Innovation And Expedite The Market Introduction Of Its Therapies
